Pages that link to "Item:Q3137703"
Jump to navigation
Jump to search
The following pages link to (Q3137703):
Displayed 50 items.
- New experimental approaches to the diagnosis and treatment of cholangiocarcinoma. (Q3137704) (← links)
- Development of new non-genotoxic conditioning regimens for haematopoietic progenitor transplantation in congenital haemoglobinopathies and autoimmune diseases (Q3138716) (← links)
- NATIONAL BIOBANK NETWORK (Q3141019) (← links)
- Development of new immunotherapy strategies for the treatment of colorectal cancer using self-replicative RNA-based vectors (Q3142633) (← links)
- Study of myocardial interstitial fibrosis in cardiac toxicity associated with breast cancer treatment. Diagnostic and therapeutic implications (Q3143334) (← links)
- Molecular analysis using state-of-the-art platforms of non-small cell lung carcinoma for the development of prognostic profiles and new therapeutic tools (Q3143483) (← links)
- Cooperative Cancer Research Thematic Network (RTICC) (Q3147474) (← links)
- Cooperative Cancer Research Thematic Network (RTICC) (Q3147479) (← links)
- Cancer Network: 2.6. Airway Cancer (Q3147702) (← links)
- PRB3 BIOMOLECULAR RESOURCES PLATFORM (Q3151727) (← links)
- Detection and functional validation of plasma cell specific non-coding long RNAs in Multiple Myeloma (Q3153691) (← links)
- Neuroimage markers of genetically determined Parkinson’s disease (Q3155797) (← links)
- Therapeutic vaccination to enhance immunotherapy against hepatocarcinoma (Q3158879) (← links)
- Transformation of the tumor environment with Aptameric immunocomplexes (IAS): from immunosuppression to immunostimulation. (Q3159565) (← links)
- Boosting immunotherapy against lung cancer by modulating innate tumor response (Q3161032) (← links)
- EXPRESSION OF CARDIOMIRS BY ADENO-ASSOCIATED VECTORS AND FUNCTIONALISED NANOPARTICLES FOR THE TREATMENT OF MYOCARDIAL INFARCTION (Q3161197) (← links)
- Biomolecular and bioinformatics resource platform, PRB2 (Q3165715) (← links)
- Cell Therapy Network: 16.1. Research, development, production and application of cellular therapy drugs in cardiovascular diseases (Q3168662) (← links)
- FUNCTIONAL DUALITY OF METALLOPROTEINASE-10 IN ATHEROTHROMBOTIC VASCULAR DISEASE (Q3175526) (← links)
- New strategy for the treatment of EA: validation of epigenetic targets, from in-vitro to a murine model of the disease. Design and development of new pharmacological tools (Q3177791) (← links)
- Induction of immunity in haematological neoplasms mediated by inhibition of NMD and enhancement of costimulation directed to the tumor. (Q3179183) (← links)
- Development of viral vectors that express immunomodulatory antibodies as a new gene therapy strategy for cancer (Q3179347) (← links)
- Role of DNA (hydroxy)methylation in the regulation of long non-coding RNAs in Multiple Myeloma (Q3180817) (← links)
- Inhibition of G9a methyltransferase activity by small molecules as a therapeutic strategy in haematological tumors (Q3181405) (← links)
- Identification and validation of diagnostic markers and therapeutic targets in lung cancer related to the activation of the complement system (Q3181560) (← links)
- Involvement of oxidase NADPH in interstitial myocardial fibrosis in heart failure (Q3190396) (← links)
- Cardiovascular Network (Q3192372) (← links)
- Characterisation of new therapeutic targets for the treatment of steatohepatitis: metabolic role of splicing factor Slu7 and its regulator anfirreguline growth factor (AR) (Q3198265) (← links)
- Development of new hepatoprotective and pro-regenerative molecules based on fibroblast growth factor 15/19 (FGF15/19) and anfirreguline (AR). (Q3198301) (← links)
- Development and characterisation of a new long-acting, non-lipogenic and liver-directed insulin (Q3199178) (← links)
- Modulation of dendritic cell activity for therapeutic vaccination against hepatocarcinoma (Q3199775) (← links)
- A new strategy for the prevention and treatment of atherothrombotic stroke: blocking of phospholipase A2 group V and administration of deglycosylated activated protein C (Q3199950) (← links)
- Potential of in vivo gene editing using CRISPR/Cas for the treatment and modeling of Primary Hiperoxaluria. (Q3202009) (← links)
- TREATMENT OF MYOCARDIAL INFARCTION AND PREVENTION OF ADVERSE REMODELING BY APPLYING GROWTH FACTORS AND ANTI-FIBROTIC MICRORNAS (Q3202095) (← links)
- Exploiting SR-B1 for the development of new immunomodular drugs to enhance cancer immunotherapy (Q3203992) (← links)
- Role of NKX2-3 homeobox protein in BCR/NF-kB signaling and cooperation with NOTCH in the development of marginal area lymphoma (Q3204503) (← links)
- Molecular tools for prognostic analysis and identification of new therapeutic targets in non-small cell lung carcinoma (Q3209276) (← links)
- Platform National Biobank Network (Q3211160) (← links)
- Cell Therapy of Primary Hyperoxaluria by Cell Reprogramming (Q3213149) (← links)
- Cancer immunotherapy using tumor-specific co-stimulant antibodies (Q4656882) (← links)
- Development of a gene therapy platform for renal genetic diseases (Q4657821) (← links)
- Development and validation of a hyperspectral system for analysis of solid tissue biopsies. QUASAR (Q4658097) (← links)
- Automatic CAR T cell production platforms for the treatment of B leukemia and B lymphoma (Q4665430) (← links)
- DEVELOPMENT OF A COMPLETE PLATFORM FOR THE ANALYSIS OF BLOOD CELLS WITH HIGH SENSITIVITY AND SPECIFICITY. PLATFORM CELL. (Q4686987) (← links)
- Comprehensive tumour and tumor microenvironment study: Molecular characterisation, genomics, transcriptomics, immunogenomics and microbiome applied to Precision Medicine of cancer (colon cancer as proof of concept). (Q4687992) (← links)
- IDP4SCLC Drug Optimisation in New IDP Therapeutic Targets (ASCL1) for the Treatment of Microcytic Lung Cancer (Q4695137) (← links)
- FIMA – RESEARCH PROJECTS MOD TO 2018/2020 (Q6844105) (← links)
- Characterisation of the reciprocal interaction oncogene/chromatin remodelers in tumorogenesis and metastasis in lung cancer. (Q6844113) (← links)
- Parkinsonisms associated with Gaucher’s disease (Q6844115) (← links)
- Expansion of infiltrating T lymphocytes in hepatocarcinoma (HepaTIL) (Q6844116) (← links)